candesartan cilexetil has been researched along with Fatty Liver in 1 studies
candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects
Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kitamura, K | 1 |
| Tada, S | 1 |
| Nakamoto, N | 1 |
| Toda, K | 1 |
| Horikawa, H | 1 |
| Kurita, S | 1 |
| Tsunematsu, S | 1 |
| Kumagai, N | 1 |
| Ishii, H | 1 |
| Saito, H | 1 |
| Hibi, T | 1 |
1 other study available for candesartan cilexetil and Fatty Liver
| Article | Year |
|---|---|
Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis.
Topics: Alanine Transaminase; Amides; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aspa | 2007 |